Skip to content

Bristol Myers Squibb Co

BMY· NYSECore metricsCIK 14272

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.92%
Market cap
$127.43B
2.04B shares
Filings
1,071
$13.07B
Q3 2026−0.2% FY25 yoy
$2.16B
Q3 2026N/M FY25 yoy
$1.40B
Q1 2012
—
$7.68B
Q3 2026derived−7.9% FY25 yoy
$1.05
Q3 2026N/M FY25 yoy
$9.57B
Q3 2026−1.3% FY25 yoy
$127.43B
13.8×
2.5×
5.4×
7.29%
4.02%

Twelve months to Sep 30, 2026 · derived

Price

$62.34+27.96%+$13.62past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$48.19BFY 2025
$48.30B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$48,194,000,000reported
FY 20242024-12-31$48,300,000,000reported
FY 20232023-12-31$45,006,000,000reported
FY 20222022-12-31$46,159,000,000reported
FY 20212021-12-31$46,385,000,000reported
FY 20202020-12-31$42,518,000,000reported
FY 20192019-12-31$26,145,000,000reported
FY 20182018-12-31$22,561,000,000reported
FY 20172017-12-31$20,776,000,000reported
FY 20162016-12-31$19,427,000,000reported
FY 20152015-12-31$16,560,000,000reported
FY 20142014-12-31$15,879,000,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$5.05B$0.00$5.05B$2.492.04B sh+0.4%39.3%
FY2024$4.86B$0.00$4.86B$2.422.03B sh+0.4%34.9%
FY2023$4.74B$5.16B$9.90B$2.312.02B sh−3.6%78.2%
FY2022$4.63B$8.00B$12.64B$2.192.10B sh−3.7%105.7%
FY2021$4.40B$6.29B$10.68B$2.012.18B sh−2.7%70.1%

Segments

Revenue by Geography, FY2018 to FY2025FY2018United States · FY2018 · $12.59BOther · FY2018 · $584.00MInternational · FY2018 · $5.66BRest of World · FY2018 · $3.73BFY2019United States · FY2019 · $15.34BOther · FY2019 · $524.00MInternational · FY2019 · $6.27BRest of World · FY2019 · $4.01BFY2020United States · FY2020 · $26.58BOther · FY2020 · $631.00MInternational · FY2020 · $15.31BRest of World · FY2020 · $5.46BFY2021United States · FY2021 · $29.21BOther · FY2021 · $852.00MInternational · FY2021 · $16.32BInternational · FY2021 · $16.32BRest of World · FY2021 · $5.63BFY2022United States · FY2022 · $31.50BInternational · FY2022 · $13.83BOther · FY2022 · $834.00MInternational · FY2022 · $13.50BInternational · FY2022 · $13.50BFY2023United States · FY2023 · $31.21BInternational · FY2023 · $13.10BOther · FY2023 · $699.00MInternational · FY2023 · $12.75BFY2024United States · FY2024 · $34.11BInternational · FY2024 · $13.20BOther · FY2024 · $996.00MFY2025United States · FY2025 · $33.28BInternational · FY2025 · $13.83BOther · FY2025 · $1.09B
LineFY2025ShareChange
United States$33.28B69%−2.4%
International$13.83B29%+4.8%
Other$1.09B2.3%+9.1%
International———
International———
Rest of World———
Total$48.19B

From the 10-K filed Feb 11, 2026BMY

Pharmaceutical preparations

Bristol Myers Squibb Co is the 7th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Bristol Myers Squibb Co · CIK 14272 · Engraved from SEC EDGAR